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Social inequalities in health are a major public concern. Some of these 
inequalities are currently not well documented, and are thus largely absent 
from debate. One important health issue is renal disease and access to 
the corresponding therapies (dialysis and renal transplant). These two 
therapeutic options have very different consequences in terms of labour 
market participation and physical well-being. Renal transplants offer 
patients an enhanced quality of daily life and a longer life expectancy, but 
this option is limited by organ availability. Here, drawing on two recent 
surveys, Christian Baudelot, Yvanie Caillé, Olivier GodeChot and Sylvie 
MerCier examine socially differentiated access to these two therapies 
and explore the underlying mechanisms. At each stage in the disease 
and its treatment, a cumulative process puts the least educated patients 
at a disadvantage in terms of access to a kidney transplant.
Renal diseases remain invisible and silent until an advanced stage. Between 
two and three million persons in France have a renal disease, but most are 
unaware of it. These diseases lead to two risks: increased cardiovascular morbidity 
and degradation of renal function, culminating in end-stage renal disease (ESRD). 
At this stage, when the kidneys no longer function, two replacement therapies 
are available: dialysis and transplant (see Appendix). The latter is the most 
effective therapy for patients of all ages in terms of survival, quality of life, and 
cost-effectiveness for the healthcare system (HAS, 2014). Yet in France, dialysis 
is most often offered as a first-line therapy, and a majority of patients who have 
reached the ERSD stage are treated in this way. Among the 76,000 persons in 
France currently treated for end-stage renal disease, 55% are in dialysis and 45% 
have received transplants. Two recent surveys (Baudelot et al., 2014, 2015) have 
highlighted social inequalities in access to these two therapies. Regardless of 
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age and sex, patients who have completed some higher education are more likely 
to receive transplants than others. This inequality of access by level of education 
is also seen in different categories of treatment: patients who receive a transplant 
from a living donor (the best therapeutic option) are more educated than patients 
who receive a kidney from a deceased donor, and patients receiving the forms 
of dialysis that offer greater autonomy – home dialysis and self-care dialysis – are 
also more likely to hold a post-secondary qualification than others.
This situation affects patients’ quality of life in many ways, and notably their 
ability to hold a job, a good indicator of a life comparable to that of most working-
age adults. Transplants are less likely to interfere with continued employment 
than dialysis, regardless of level of education. How can such large differences 
by educational level be explained? This article attempts, within the limitations 
of the available data, to better understand the origins of these inequalities in 
access to the best therapy for renal diseases (renal transplantation), and the 
relationships between the different factors that produce these inequalities.
I. Sources
We draw on two recent surveys that are relevant to understanding social 
inequalities in access to therapy for renal diseases. 
The 2012 États généraux du rein survey
A patient questionnaire was drawn up jointly by all the stakeholders of a 
kidney patients’ forum known as États généraux du rein (EGR)(1) who were 
represented on its scientific committee. The survey was administered over a 
six-month period, from July to December 2012, with the help of patients’ 
associations and hospital federations which disseminated the questionnaire 
to healthcare centres and patients’ homes. A total of 8,613 completed 
questionnaires were returned, including 6,185 paper questionnaires and 2,428 
by Internet (at the time, the population of ESRD patients was estimated at 
74,000). In terms of age and sex, the sample was highly representative of the 
population of all ESRD patients, as recorded in the Renal Epidemiology and 
Information Network (REIN) registry. This survey offers new information on 
patients’ social characteristics by way of a variable indicating their level of 
education – their most recent educational qualification – which is a first in 
nephrology.(2)
(1) http://www. renaloo.com
(2) Level of education offers a good approximation of social status. “Education is probably the indicator 
most widely used in epidemiological surveys and follow-up data, because it offers a number of advantages: 
it is easy to obtain, it generally remains stable over individuals’ lives (after they complete their education), 
it does not depend on current labour market status and thus provides information on the socioeconomic 
status of non-employed individuals; it is also unaffected by later state of health, and is easily comparable 
in international studies.” Indicateurs de suivi des inégalités sociales de santé [Indicators for monitoring 
social inequalities in health], Report of the Haut conseil de la santé publique, 19.06.2013.
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This is the first time that persons previously and currently affected by renal 
failure have been consulted on this scale in France. This body of data provides wide-
ranging information on the ways in which patients experience their diseases and 
treatments (Baudelot et al., 2014, 2015). The full results of this survey are presented 
in the final report of the États généraux du rein (EGR, 2013). 
The 2011 Quavi-REIN survey 
This second survey was carried out under the aegis of the Agence de la 
biomédecine (ABM), by the department of epidemiology and clinical assessment 
of the Nancy university hospital. This cross-sectional survey was administered 
in 2011 by self-completed questionnaire to patients in the 21 regions who were 
members of the REIN network in 2009. The survey sample included 2,909 ESRD 
patients stratified by region and age, including 1,251 dialysis patients and 
1,658 transplant recipients. The questionnaire included a medical variable drawn 
from the REIN and CRISTAL registries of the ABM, indicating the patients’ initial 
diagnosis (this information was provided by nephrologists at the time of 
registration) and a number of social variables: occupation, employment status, 
company size, salary and income levels, and level of education as measured by 
the last educational qualification obtained. The educational distribution of the 
population was very similar to that measured by the EGR survey. The employment 
status of patients aged 25-65 was measured at two points: before reaching ESRD, 
and after beginning replacement therapies; i.e. dialysis or transplantation. 
The EGR survey has the merit of revealing new information, but does not 
include a medical variable on the nature of the patients’ pathologies. Although the 
survey population is large (N = 8,613), it was not obtained via a systematic sampling 
process. It consists of volunteers, and thus cannot be considered representative, 
even though the age and sex distribution corresponds to that of the total population. 
The Quavi-REIN survey sample, by contrast, was randomly drawn from an ABM 
patient register, after stratification by age and region. It includes variables identifying 
the original renal pathology and the region, as well as the dates of onset of end-
stage renal disease (first dialysis), registration on the waiting list, and the first 
transplant (with or without a preceding period of dialysis). It thus provides an 
opportunity to analyse more fully the emergence of observed social inequalities, 
although age at diagnosis is not included in the data.
II. Hypotheses and factors associated 
with inequalities in access to care
Three families of factors, which are not mutually exclusive, can be identified.
Pathology and/or blood group 
Certain renal diseases that affect the poor more than the wealthy are 
contraindicated for kidney transplantation, or have potentially poor transplant 
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outcomes. The distribution of different renal diseases varies across social 
groups (Quavi-REIN survey). Greater absolute numbers of working class people 
are affected by vascular diseases, diabetes, and obesity, and consequently by 
their effects on renal function. The kidney is ultimately affected, but it is not 
the cause of the disease. More educated patients are more likely to develop 
disorders of more specifically renal origin, such as genetic diseases (polycystosis, 
etc.), glomerulonephritis, and systemic diseases. Pathologies in the first group 
(vascular diseases, diabetes, obesity) are more likely to contraindicate transplant, 
and thus delay registration on the transplant waiting list, than pathologies in 
the second group.(3) The category “unknown diseases” in the REIN database 
designates renal pathologies that are too advanced at the time of diagnosis for 
the nephrologist to confidently identify their cause. Patients in this category 
often come to hospital as an emergency case. 
The Quavi-REIN survey confirmed that individuals with low levels of 
education are over-represented on the renal transplant waiting list. This means 
that these populations wait longer for a compatible kidney. The principal factors 
that increase waiting time are blood group and anti-HLA immunization.(4) To 
what extent are these factors correlated to patients’ social characteristics?
Blood group B (9% of the French population) is much more common in 
populations with origins in certain parts of Africa, who also exhibit higher 
prevalence and faster progression of renal insufficiency. It is likely that patients 
(3) To receive a transplant, a patient must first be registered by a nephrologist on the national waiting 
list managed by the Agence de la biomédecine.
(4) HLAs (human leukocyte antigens) are proteins located at the surface of cells that allow the 
immune system to distinguish the body’s own cells from other cells. The human body is able to 
produce specific antibodies against HLAs from other people. This can occur through contact with 
these foreign antigens, following blood transfusion, pregnancy, or a previous transplant, for example. 
This is described as immunization. If a patient is immunized against a large number of HLAs, it can 
become more difficult to find a compatible organ for transplantation. An organ with these antigens 
would trigger a rejection response in the recipient’s immune system. 
Table 1. Distribution of renal diseases by patients’ level of education
Highest 
qualification
Diabetes 
mellitus  
and vascular 
diseases
(%)
Genetic 
diseases  
and 
polycystoses
(%)
Glomerulonephritis, 
systemic disease,  
and tubulointerstitial 
diseases
(%)
Unknown
(%)
Total
Number of 
individuals
Primary 24 15 40 20 100 724
Lower secondary 18 18 42 23 100 536
Upper secondary 12 23 47 18 100 594
Higher ed. ≤ 3 years 12 21 49 17 100 392
Higher ed. > 3 years 11 22 52 15 100 285
Total 17 19 45 19 100 2,531
Interpretation:  Among respondents with a primary education, 24% have diabetes mellitus or vascular disease. 
Source: Quavi-REIN survey, REIN registry, Agence de la biomédecine.
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who are immigrants or descendants of immigrants from these regions, who 
form a population with a lower average level of education, make up a significant 
proportion of group B patients who are awaiting a transplant. On 1 January 
2012, there were 1,460 such patients, or 16.1% of the total number of patients 
on the waiting list, and they had been waiting for much longer than other 
groups. 
Are there links between antibody status and social status? One possible 
factor is the higher frequency of pregnancy in populations with a lower level 
of education. But it is difficult to pursue this point further and identify possible 
correlations between level of education and other causes of immunization such 
as blood transfusions or previous transplants (Footnote 4).
Medical care and organization of the healthcare system
 Nephrology is a highly compartmentalized speciality, and communication 
between its two components, dialysis and transplantation, is very limited. 
These two complementary and competing therapies exist as two separate 
spheres within nephrology. Transplants are carried out only in university 
hospitals and in departments with a large research component. Dialysis is 
divided roughly equally between public and private institutions, and community 
structures. Over time, it has become an integrated and financially profitable 
industrial system, with its own laboratories, clinics, and manufacturers of 
equipment and supplies. The generalization of a fee-for-service system, with 
dialysis costs entirely covered by the French social security, associated with 
the guarantee of a “captive clientele” (in the majority of cases, for three sessions 
a week) has created an incentive for public and private institutions to increase 
the number of dialysis stations for accounting reasons. Under the fee-for-service 
system, dialysis generates a large income for the institutions that provide it. It 
is also among the most profitable of all medical activities (DREES, 2014). In 
2015 the French Court of Auditors (Cour des comptes) published a report on 
the particular structure of this treatment system. They observed large disparities 
in the orientation and care of patients, insufficient recourse to transplantation 
(notably from living donors), and disproportionate use of the most high-tech 
dialysis methods. The report also highlighted the adverse effects of this profit-
seeking approach on patients’ trajectories: ineffective strategies for prevention 
and care of renal diseases, premature initiation of dialysis in some cases, 
insufficient referral for transplantation (Cour des Comptes, 2015). To explain 
this situation, which penalizes both patients and the public health insurance 
system, the report pointed up the shortcomings of the dialysis financing system 
(fee-for-service payments to institutions and nephrologists), which creates 
incentives to favour in-centre dialysis, the most high-tech and costly dialysis 
option, to the detriment of alternative options.
There are also large geographic inequalities in waiting list registration, 
waiting times, and access to transplantation. These inequalities are precisely 
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measured each year in the REIN report issued by the Agence de la Biomédecine. 
In 2011, median waiting times ranged from 7.4 months (minimum) to more 
than 52 months (maximum). Strategies for registration on the list, which 
themselves vary widely between regions and even institutions, can also play 
a role. The less restrictive strategies observed in some regions have a manifest 
impact on the level of shortage and thus on waiting times. They prolong waiting 
times, but decrease the effect of level of education on access to the waiting list. 
In these regions, the filter effect of pathologies associated with poverty, such 
as diabetes and obesity, is much lower. These strategies reflect regional medical 
rationales that are clearly favourable to transplantation: practitioners in these 
regions provide information more widely and more systematically, reducing 
the effects of privileged access by the most highly educated patients to medical 
advice and longer consultations. 
This hypothesis can be illustrated with two “extreme” examples. In 2011, 
87% of dialysis patients under age 60 were on the waiting list in the Paris 
region (Île-de-France). The corresponding figure in the Provence-Alpes-Côte 
d’Azur (PACA) region was only 36%. These differentials were even more marked 
for older patients. Median waiting times in the two regions reflect the respective 
levels of mismatch between supply and demand: 36.7 months in Île-de-France 
versus 12.6 months in PACA. 
Another factor in the care of renal disease concerns the ways in which 
decisions to allocate an organ are influenced by positive or negative expectations 
about how the patient will behave after the transplant. Negative expectations 
play a role, for example, in liver transplants. They “explain” in part why patients 
with alcoholic cirrhosis are less often offered a liver transplant, even though 
their prognosis is no different from that of non-alcoholic patients. A recent 
article showed that in the United States, black and low educated patients are 
substantially more likely to be allocated a kidney on “expanded criteria” – i.e. a 
kidney that comes from an older or less healthy donor, and that is thus of lesser 
quality (Mohandas, 2013). The major role of patients’ insurance coverage in 
the United States is well-known, notably with regard to transplantation. ESRD 
therapies are very costly. Patients without private insurance depend on Medicare, 
which covers transplantation and immunosuppressive treatment expenses for 
a maximum of three years (Gill et al., 2013). After this period, for patients 
under age 65 who are not diabetic, medication is no longer reimbursed. This 
results in a high rate of treatment discontinuation, which in turn largely 
explains why survival rates five years or more after kidney transplant in the 
United States are lower than those in countries where immunosuppressants 
are covered indefinitely. It has also been shown that transplant teams in the 
United States are more reluctant to register and transplant socially disadvantaged 
patients, notably because they often have no health insurance (Morgan, 2013).
This reasoning does not apply in France, where all patients are fully covered 
by the health insurance system for an unlimited period, and where renal 
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transplants are distributed on the basis of a score based on efficacy and equity 
criteria that, in theory, leave no room for such considerations. However, 
exemptions are granted for locally allocated kidneys which, in 2012, represented 
46.8% of the organs transplanted in France. A kidney is considered local when 
it is allocated to a transplant team in the same institution or network as the 
unit that harvested it. The local team is then required to allocate the organ on 
the basis of the scores of the recipients on its local list, but is free to decide on 
the basis of other criteria, provided that it has good grounds for doing so. In 
total, in the year 2009, 43 out of every 100 harvested kidneys were transplanted 
locally.
It can be hypothesized that in certain cases, transplant surgeons decide 
to preferentially allocate the best organs, an increasingly rare resource, to 
patients whose level of education suggests that they will better understand the 
constraints of a transplant and will follow instructions more scrupulously. In 
any case, this is the pattern found in the United States (Janezko, 2013; Tandon, 
2013). In a survey of American nephrologists, the three most often cited reasons 
for excluding certain patients from the waiting list were inadequate social 
support  (70% of respondents), “limited understanding of the transplant process 
due to patient’s inadequate education” (56%), and age above 65 (53%). In France, 
data on the actual use of such exclusion criteria are not currently made publicly 
available. 
Patients’ social characteristics and how they cope with their disease
Individuals with a relatively high level of education and who exercise a 
higher-level occupation are more likely to pay attention to their health and to 
warning signs of disease, particularly by monitoring blood pressure (Boltanski, 
1971). More educated individuals are also better able to find their way around 
the world of medicine, and more often gain access to the best therapies (Leclerc 
et al., 2000). They are also the best informed, in nephrology as in other 
pathologies. They are more likely to report having been well or very well 
informed on the two categories of transplant (living or deceased donor) and, 
above all, they are more likely to “often or continuously” seek out information 
on their diseases and therapies beyond what they learn from their nephrologist. 
According to the EGR survey, in 2012 this was true of 14% of patients with 
less than secondary education, 33% of those who had completed secondary 
school and 42% of those with at least three years of higher education (EGR 
survey). Members of the most educated social groups are also known to see 
physicians earlier and more often than members of the working class. They 
also apparently have fewer difficulties in effectively implementing strategies 
to preserve renal function: consuming a diet low in salt and protein, controlling 
blood pressure, etc. Their renal diseases also tend to develop more slowly, 
giving them an advantage in access to systems for early detection and diagnosis 
and to more effective therapies for slowing the course of the disease.
Renal Diseases anD social inequalities in access to tRansplantation in FRance
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How can the respective effects of these three families 
of factors be measured?
As we have seen, inequalities in access to transplantation seem to result 
from several classes of factors with different origins. To better understand 
the hierarchy of these factors, and to determine whether they are cumulative 
or mutually compensatory, the ideal solution would be to have reliable 
objective indicators for each of these three families of factors, and to run a 
multivariate analysis to determine the relative weight of each one. At present, 
these indicators are not all available.(5) The Quavi-REIN survey data include 
reliable indicators for the first family of factors (initial pathology reported 
by the nephrologist), the second (region, waiting times before registration 
on the list and for a transplant), and the third (patients’ level of education). 
No variable is available, however, to test the role of blood group, immunization, 
or negative expectations. Likewise, our data cannot be used to measure the 
effect of the duality of the treatment system on inequalities in access to 
transplantation. We are thus limited to measuring these inequalities at the 
individual level.
Using the variables available in the survey data, we can, however, attempt 
to assess the relative contribution of each of these three factors – initial 
pathology, region, level of education – after controlling for sex and age. To do 
so, we use logistic regression models on the probability of obtaining a transplant, 
all other things being equal, and so-called Cox proportional hazards models 
of waiting times, which account for differences in speed of access to 
transplantation. In terms of structure and interpretation, the Cox model is 
very similar to a logistic regression model: it accounts for the time taken to 
move from one state to another. It models the rate of exit from a given state 
(from dialysis to transplant), taking account of the fact that certain exits are 
“censored”: they had not yet been observed at the time of the survey and may 
occur later. The model thus measures the difference in the odds of going from 
one state to another after an equivalent time spent in the first state. This 
proportional hazards model can be written as follows:
hi(t) = h0(t) . exp( b1.xi1 + ... +  bk.xik), 
where xik represents the value of the explanatory variable k for individual i, bk 
the estimated parameter for this variable, and h0(t) an undefined baseline 
hazard function. The latter can be interpreted as the risk of experiencing the 
event for an abstract reference individual whose individual characteristics xik 
(5) An ongoing longitudinal survey will soon be able to measure these factors, but the first results 
will not become available for several years. The CKD-REIN (Chronic Kidney Disease) cohort consists 
of 3,600 patients followed for at least five years in order to “understand how lifestyle, environment, 
genetics, and medical practices interact in chronic kidney disease”. The project coordinator is Bénédicte 
Stengel, and it includes 11 institutional partners: several universities and university hospitals, INSERM, 
the Agence de la biomédecine, the Centre national de génotypage [National genotyping centre], the 
Picardie Biobanque, and Arbor Research (United States).
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are all zero at time t. In this model, the odds ratio hi(t)/hj(t) of experiencing 
the event for two individuals i and j, who differ on a single characteristic xk, 
does not depend on time t, only on the ratio exp(bk.xik)/exp(bk.xjk). Note that 
we deliberately chose not to introduce age at the time of the survey, which can 
be considered as a “post-treatment” variable that depends on the dependent 
variable (here, precisely, the treatment received). Although year of birth is not 
“post-treatment”, survival itself depends on the treatment received, making 
age at the time of the survey endogenous. Moreover, if we were to introduce 
age at the time of the survey in addition to age at the onset of ESRD, the 
probability of transplantation would increase with age at the time of the survey, 
no doubt reflecting the higher survival rate of transplant recipients in comparison 
to dialysis patients for a given age at ESRD onset. The introduction of this 
variable, suspected of endogeneity, also leads to larger and more significant 
differences by level of education.
III. Results
Inequality in access to therapies was reflected in EGR survey data by the 
coexistence of three populations with highly differentiated levels of education: 
dialysis patients who were not registered on the national transplant waiting 
list (73% had lower secondary education, 27% had completed upper secondary 
or higher education); patients (still) in dialysis but who were registered on the 
waiting list (65% lower secondary, 35% upper secondary or higher); and patients 
who had already received a transplant (44% lower secondary, 56% upper 
secondary or higher). Dialysis patients not registered on the waiting list thus 
had a lower level of education than those who were registered, who in turn 
were less educated than those who had received a transplant. The samples for 
each of these three populations are large enough to neutralize random variations 
(3,497 nonregistered dialysis patients, 1,534 registered dialysis patients, 
1,625 transplant recipients).
Such differences in the distribution are akin to a selection process, since 
the immense majority of transplant recipients were previous dialysis patients 
who went through the two preceding stages, i.e. non-registered dialysis patient 
and then registered dialysis patient. But the explanation for this process is far 
from simple (Figure 1).
The EGR survey also established that the number of years between the initial 
diagnosis of renal disease and the terminal stage, when replacement therapy is 
used, increases consistently with patients’ level of education. For the whole 
population of respondents who had received replacement therapy before 
responding to the survey, the mean interval was 5.2 years. Dividing the population 
into groups by level of education, group means ranged from 2.9 years with 
primary education to 7 years or more for individuals with two or more years of 
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higher education.(6) The intervals for those with lower secondary or upper 
secondary education fell between these values. Time is a strategic variable in 
this context: when the interval is longer, patients have more time to learn about 
the different therapies available and choose the one best adapted to their pathology 
and living conditions. This inequality widens even further when dialysis and 
transplant patients are measured separately. Whatever their level of education, 
the period between diagnosis and end-stage disease is longer for transplant 
recipients than for dialysis patients. But this period also increases with level of 
education. It varies from as little as two years for dialysis patients with primary 
education to nearly ten years for the most educated transplant recipients (Figure 2). 
Is this a question of later diagnosis or faster disease progression?
Medical factors do not explain all the differences
Table 2 presents the statistical results of the Quavi-REIN survey and 
indicates the probability of receiving a transplant and of being registered on 
the waiting list for a transplant, for a comparable situation. The regressions 
performed here with more precise models (incorporating, for example, waiting 
time for a transplant) and a larger set of explanatory variables (region, registration 
on the waiting list, and type of disease) confirm the results of the EGR survey 
as well as the descriptive results established by an earlier study on the same 
data (Baudelot et al., 2014, 2015). Here again, the largest differences in access 
to transplantation are found between patients with different renal diseases: 
(6) The breakdown by level of education was slightly different in the two surveys. In the Quavi-
REIN survey, the levels were “primary”, “lower secondary”, “upper secondary”, “up to 3 years higher 
education” and “more than 3 years higher education”. In the EGR survey, they were “no qualifications”, 
“lower secondary diploma” “upper secondary diploma”, “up to 2 years completed higher education” 
and “more than 2 years completed higher education”. 
Figure 1. Distribution of patients by educational level 
in the three stages of the process (patients aged 45-60)
Percentage
Nonregistered dialysis patients Registered dialysis patients Transplant recipients
72.9 
64.5 
44.2% 
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35.5 
55.8% 
0 
10 
20 
30 
40 
50 
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70 
80 
INED
027A16
Lower sec. Upper sec. and higher
Source:  EGR survey.
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all other things being equal, a patient with end-stage renal disease due to a 
genetic condition is more than four times more likely to receive a transplant 
than a patient with diabetes or a vascular disease. The principal factor explaining 
inequality in access to transplant between patients is indeed a medical one. 
However, this does not cancel out the effect of education, which is far from 
negligible: all other things being equal, persons with more than three years of 
higher education are still more than twice as likely to receive a transplant as 
those with a primary education. Whatever the time spent in dialysis, individuals 
with more than three years of higher education are 1.6 times more likely to 
cease dialysis due to a kidney transplant than persons with no more than 
primary education (Table 2).
Registration on the waiting list 
These regressions provide further details about the time in the patient’s 
trajectory when the difference by level of education emerges. To receive a 
transplant, a patient must first be registered by a nephrologist on the national 
waiting list managed by the Agence de la biomédecine. As columns 6 to 9 of 
Table 2 show, it is at this stage that significant differences between groups 
arise, all other things being equal, whether in the probability of registration 
(column 8) or in the delay until registration occurs (time between first dialysis 
and registration, column 9). Once patients are registered, on the other hand, 
and whatever the subsequent transplant waiting time, the overall significance 
of the education variable is much lower than in regressions on access to 
transplantation for the entire population and/or those registered on the waiting 
list. The comparison of the Kaplan-Meier curves clearly illustrates this point 
(Figures 3, 4, and 5). The profiles of the curves for time before access to 
transplantation by level of education are very similar to those of time before 
Figure 2. Mean interval between diagnosis and end-stage renal disease by 
type of replacement therapy and educational level
0 
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3 
4 
5 
6 
7 
8 
9 
10 
Primary Lower secondary Upper secondary Higher ed. ≤ 2 years Higher ed. > 2 years
Years INED
028A16
Dialysis Transplant
Source: États généraux du rein survey.
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Figure 3. Waiting time before obtaining a kidney transplant for the whole 
ESRD population, by level of education
Primary 
Lower sec.
Upper sec.
Higher ed. ≤ 3 years
Higher ed. > 3 years
Time (years)
INED
029A16
0 10 20 30 40
Percentage still in dialysis
100
80
60
40
20
0
Interpretation:  These Kaplan-Meier curves show the proportion of the ESRD population still in dialysis that 
has not yet received a kidney transplant. Five years after beginning dialysis, 62% of patients with primary 
education are still in dialysis. 
Source: Quavi-REIN survey.
Figure 4. Waiting time until registration on the kidney transplant waiting list, 
by level of education
Time (years)
0 10 20 30 40
INED
030A16
Percentage unregistered
100
80
60
40
20
0
Primary 
Lower sec.
Upper sec.
Higher ed. ≤ 3 years
Higher ed. > 3 years
Interpretation:  These Kaplan-Meier curves show the proportion of the ESRD population not yet registered on 
the waiting list to obtain a kidney. Five years after beginning dialysis, 59% of patients with primary education 
are still in dialysis. 
Source:  Quavi-REIN survey.
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access to registration (Figures 3 and 4), which themselves differ substantially 
from the profiles of access to transplantation after registration (Figure 5). 
The only other significant differences that explain why not all those on 
the waiting list had received a transplant at the time of the survey are medical 
in nature (columns 12 and 13 of Table 2): all other things being equal, patients 
with genetic and “unknown” pathologies are twice as likely to have received 
a transplant as patients with vascular diseases or diabetes. 
The different categories of transplant
While transplantation is currently the best possible therapy for ESDR, 
not all grafts are of equal quality. The best outcomes are achieved with a 
pre-emptive transplant from a living donor. This has been amply demonstrated 
by studies in numerous countries. A pre-emptive transplant is one that is 
performed directly, without a previous period of dialysis. While only a 
small minority of transplants in France are pre-emptive (354, or 12% of 
the 3,074 kidney transplants performed in 2013), this option avoids all the 
medical, social, and human costs of dialysis. These transplants work better 
and longer than those performed after one or more years of dialysis, and 
it has been clearly shown that the longer the preceding period of dialysis, 
the greater the failure rate of a subsequent transplant (Meier-Kriesche and 
Kaplan, 2002).
Figure 5. Waiting time before obtaining a kidney transplant among patients 
registered on the waiting list, by level of education
Primary 
Lower sec.
Upper sec.
Higher ed. ≤ 3 years
Higher ed. > 3 years
Time (years)
0 5 10 15 20 25
INED
031A16
Percentage still in dialysis
100
80
60
40
20
0
Interpretation: These Kaplan-Meier curves show the proportion of the population registered on the kidney 
transplant waiting list. Two years after registration, 23% of patients with primary education had not yet 
received a transplant.
Source: Quavi-REIN survey.
Renal Diseases anD social inequalities in access to tRansplantation in FRance
15
002-PopE1-BaudelotEtAl-2016.indd   15 24/05/16   16:02
As well as alleviating the shortage of organs from deceased donors, 
transplants from living donors guarantee that the transplanted organ will 
be of excellent quality. Numerous examinations ensure that only kidneys 
with optimal function are harvested. The standards applied in France are 
among the most selective in the world: individuals whose renal function is 
below 80% of the maximum level are excluded from donating. Ischaemia 
time – that is, the waiting time before the harvested organ is transplanted 
– is reduced to a minimum, as the procedures are organized simultaneously. 
Moreover, the availability of a living donor is the scenario most conducive 
to pre-emptive transplantation, although only 135 of the 354 kidneys 
transplanted pre-emptively in 2013 (35%) were from a living donor. All of 
these conditions ensure the best possible conditions for survival of the graft.
The Quavi-REIN survey shows that this optimal scenario is not evenly 
distributed across all social categories (Table 3). In the observed sample, 8% 
of individuals with up to three years of higher education received a transplant 
from a living donor. Columns 3 and 4 present the odds ratios, as calculated 
by the multinomial model, between the probability of remaining in dialysis 
versus receiving a transplant from a deceased donor, and of receiving a 
transplant from a living donor versus a deceased donor. All other things 
being equal, this group’s probability of receiving a transplant from a living 
donor rather than a deceased donor was 1.88 times higher than that of persons 
with primary education (significant at the 10% level). When levels of education 
are grouped together, the odds of patients with upper secondary or higher 
education obtaining a transplant from a living rather than a deceased donor 
were 1.66 times higher (significant at the 5% level) than those of patients 
with a primary or lower secondary level of education.
The two final columns present the odds ratios, as calculated by the 
multinomial model, for the probability of either remaining in dialysis or 
receiving a pre-emptive transplant, as opposed to receiving a transplant after 
dialysis. All other things being equal, persons with more than three years 
of higher education were 2.3 times more likely to receive a pre-emptive as 
opposed to a standard transplant than persons with primary education 
(significant at the 5% level). In both cases, the more highly educated had an 
advantage. 
The poorest and least educated patients are affected by a cumulative 
disadvantage. They are more often concerned by pathologies that are 
contraindicated for transplantation or that complicate the transplant procedure 
and make the outcome more uncertain. They wait longer than others to be 
registered on the waiting list and, whether or not they receive a transplant, 
they are only qualified to do jobs requiring levels of physical energy that are 
difficult to reconcile with their state of health. The “work-resources” component 
of the Quavi-REIN survey gathered information on two distinct moments in 
the trajectory of patients aged 25-65 years: before and after reaching end 
C. Baudelot et al.
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stage renal disease. The transition from one to the other is accompanied by 
a massive decrease in labour force participation rates, whose scale varies 
according to the type of therapy received. The rate fell from 63% to 17% among 
dialysis patients who had not been offered a transplant, from 78% to 51% 
among those who received a transplant following a period of dialysis, and from 
78% to 59% among those who received a transplant without a previous period 
of dialysis. All were aged below 65 years at the time of the survey (Figure 6).
IV. Discussion
Social inequality in access to transplantation is not a French exception
The international literature shows clearly that social inequality in access 
to transplantation revealed by the EGR and Quavi-REIN surveys is not specific 
to France. Many studies based on large samples have been published in respected 
journals in the United Kingdom and North America, as well as in Brazil, 
Germany, Hungary, Australia, and New Zealand. Whatever the variable, all 
reveal large social disparities by income, level of education, and ethnic origin. 
Low socioeconomic status is associated with higher incidence of renal 
pathologies, more frequent transition to end-stage renal disease, inadequate 
dialysis, and reduced access to transplantation, compounded by the effects of 
poor general health (Patzner et al., 2012). Black and Hispanic patients wait 
longer than others before being registered on waiting lists (Joshi et al., 2013). 
The literature on the effects of these factors on access to transplantation is 
very substantial and explicit, as the title of one publication suggests: “Do you 
need to stay in school to get a kidney transplant?” (Fink, 2008). Evidence 
Figure 6. Labour force participation rate of patients aged below 65 before 
and after onset of end-stage renal disease, by type of therapy
Percentage
Dialysis Transplant after dialysis Transplant without dialysis
63.1
77.9 77.9
16.8
50.7
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Source: États généraux du rein survey.
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shows that there are large disparities between African Americans and Caucasians, 
as well as between Hispanics and Caucasians. 
Many factors explain these disparities: the “preferences” of patients and 
doctors, socioeconomic status, insurance coverage, level of education, and 
immunological factors. One article examined the action of all of these causes 
of inequality in access to transplantation in the United States. (Joshi et al., 
2012). Individuals at the top of the socioeconomic pyramid are more likely to 
receive transplants from living donors than individuals at the bottom (Grace 
et al., 2013; Gill et al., 2012). Survival data on both dialysis and transplantation 
by income, level of education and ethnic origin show that in both cases, patients 
live longer if they are white, educated, and affluent (Kimmel et al., 2013; Begaj 
et al., 2013). Poor and black patients are more likely to be allocated a kidney 
on expanded criteria (Janezko, 2013). 
Renal diseases are not an exception in the medical landscape
The social distribution of these diseases follows a pattern that is also found 
in most other pathologies. Here too, different social categories do not benefit 
equally from the medical progress resulting from preventive measures 
implemented at the three stages of the disease. Lesser exposure to risk factors 
decreases incidence of the disease. Although no particular occupations have 
been identified as particularly nephrotoxic, the fact that the least educated 
population categories are more likely to suffer from arterial disorders, diabetes, 
and obesity suggests that poor nutrition and hypertension, two major risk 
factors for kidney damage, are not monitored and managed to the same extent 
in all segments of society. Similarly, in showing that the number of years 
separating initial diagnosis from ESRD increases progressively with level of 
education, the EGR survey confirms that different social classes do not adhere 
equally to the specific dietary and lifestyle constraints that can slow the course 
of the disease. Finally, at the most advanced stage, when replacement of renal 
function becomes necessary, the most educated groups more often benefit from 
the best available therapy, namely transplantation.
Theoretical models of disability are also fully applicable to the effects of 
renal pathologies on patients’ quality of life, insofar as changes in renal function 
lead to disabilities or activity limitations and, over time, to major social 
disadvantages, and even to exclusion from employment (Verbrugge and Jette, 
1994). For the least educated groups who often have physically demanding 
jobs, regular dialysis sessions and poor overall health make it difficult to stay 
in employment. This contrasts with the situation of more educated patients, 
who more often benefit from a transplant, and who typically perform sedentary 
jobs requiring work that is more intellectual than physical. 
The life course of these patients can be seen in terms of the “accumulation” 
model in life course epidemiology, and notably its longitudinal dimension, 
which looks at how medical and social disadvantages accumulate over the life 
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course. Neither dialysis nor transplantation provide a cure for the disease, and 
the side effects of treatments, as well as accelerated ageing, limit the number 
of activities that patients are able to perform, among which employment is the 
most strategic (Blane et al., 2007; Link and Phelan, 1995).
Organ donations: efficacy or equity?
Renal pathologies do, however, present an original characteristic. ESRD 
can be treated in two ways, one of which, transplantation, is now clearly the 
best in terms of life expectancy, quality of life, and public cost. Among all the 
results presented in this article, the most spectacular relates to the observed 
difference, in terms of social inequalities, between two stages in the treatment 
process: registration on the waiting list and access to transplantation. There 
are large differences in registration by level of education, but once this threshold 
has been crossed, these differences are no longer found for access to 
transplantation. What explains this contrast? Once patients are registered on 
the list, apart from the above-mentioned possibility of giving priority to 
transplants performed in the hospital where the organ is harvested, it is no 
longer physicians who decide whether or not a patient will receive a transplant, 
but a score calculated by an algorithm.
Organ scarcity has led most countries to establish waiting lists, and to 
define rules for distribution and allocation of organs harvested from brain-dead 
individuals. In France, these rules are based on two principles: equity between 
patients and medical efficacy.
In terms of medical efficacy, defined as the “degree to which an intervention 
accomplishes the desired or projected outcomes”, organ allocation takes account 
of tissue group compatibility (number of donor-recipient incompatibilities in 
the six HLA loci), and of the age difference between donor and recipient. 
In terms of equity, a statistical index of “ease of access to transplantation”, 
which favours patients for whom it is difficult to find a suitable organ for 
immunological reasons (notably due to anti-HLA immunization) is also an 
important criterion, as is the time since registration on the list and since the 
start of dialysis. 
Each of these factors is weighted and fed into a national algorithm which 
calculates a compatibility score for all patients on the waiting list each time a 
new graft becomes available. A list of potential recipients is then drawn up, in 
decreasing order of priority. It is not surprising, then, that this algorithm 
should be indifferent to patients’ level of education. Indeed, its neutrality is a 
sign of its quality, showing that it ensures equality of treatment between 
patients. This is not true “upstream”, at the stage of registration on the waiting 
list, where nephrologists’ decisions about whether or not to include a patient 
is by no means anonymous. At this stage, the decision is made in full awareness 
of all the patient’s characteristics, including not only medical but also other 
individual and behavioural aspects. It cannot be ruled out that, under these 
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conditions, a medical efficacy criterion – whereby doctors preferentially register 
patients whose state of health and personal characteristics lead them to expect 
a greater life expectancy benefit from scarce donated organs – wins out over 
the criterion of equity. This is currently only a hypothesis and cannot be 
validated using the available data, but studies in other countries have shown 
that it is well-founded (Janezko, 2013; Tandon, 2013). Jon Elster (1992) 
extensively studied the different justice criteria that are applied in allocating 
scarce resources, and notably in the case of organ donations. He highlighted 
the tension between two types of logic: need (who is most in need of a transplant 
at a given moment?) and social efficiency (which potential transplant recipient 
will maximize collective well-being?). Efficiency also means maximizing total 
remaining life-years, i.e. giving priority to young people with long life 
expectancies who will adhere to their therapeutic regimen. Comparing two 
countries, one where organs are scarce, the other where they are abundant, he 
shows that countries where the resource is scarcer focus more on efficiency 
criteria. This choice may favour the most educated. 
The available data do not allow us to identify the wide spectrum of reasons 
why patients are not registered on the waiting list for an organ. However, 
surveys on the question performed in other countries suggest some hypotheses 
that are worth testing: low expectations of graft survival in light of the patient’s 
behavioural characteristics, patients’ decisions, the institutional logic of 
healthcare centres, inter-regional differences in medical cultures, incentive 
effects of pricing systems, pressure from the management of public and non-
profit institutions and from the shareholders of private institutions, etc. Only 
through an independent survey endowed with sufficient resources will it be 
possible to assess the respective roles of these factors in France. 
Conclusion
Various measures could be taken to attenuate these social inequalities. 
The first step would be to stop acting as if they cannot exist, but rather to 
acknowledge and address the problem, in line with the first recommendation 
of the report of the Haut conseil de la santé publique, Sortir de la fatalité 
(Breaking with fatalism). The addition of social variables, level of education 
and a “geographical index of social disadvantage”, to the registry of the Agence 
de la biomédecine will contribute substantially.(7) It would also be useful for 
each nephrology department to address these questions, examining its own 
practices in the light of this issue, by seeking, for example, to measure the 
existence and scale of the phenomenon in local context.
(7) To compensate for the lack of individual socioeconomic data, the socioeconomic characteristics 
of areas of residence are often used. In France, “ecological disadvantage indices” have been developed 
for this purpose. The IRIS code, the most widespread of these, is inspired by the “deprivation index” 
created by UK authorities at the ward level.
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Beyond this necessary awareness, corrective actions may also be considered, 
notably the expansion of living donor transplants, which could alleviate the 
shortage of organs from deceased donors. 
In general, all improvements in access to the waiting list and to transplantation 
will help to reduce these social inequalities. Since the États généraux du rein, 
there has been a marked institutional determination to see such changes 
through. In December 2015, the Haute autorité de santé published a code of 
good practice for access to the national renal transplant waiting list. They 
specify categories and criteria for registering patients approaching the terminal 
stage of chronic renal insufficiency (including elements from the pre-transplant 
assessment) as well as a periodic review of the reasons for non-registration.  
Experiments on care pathways in renal insufficiency, to be carried out as 
part of the national health strategy, will be initiated in 2016 in six regions. 
One of the main stated objectives of these initiatives is to promote access to 
the transplant waiting list. Two new measures will be introduced to achieve 
this goal:
•		notification,	information,	and	orientation	systems	for	patients,	designed	
to offer them the freedom to choose their own care pathway and therapies, 
as part of a medical decision made jointly with their physician;
•		multidisciplinary	coordination	meetings,	collegial	review	of	patients’	
files – by medical experts from different disciplines, but also by 
paramedics – to ensure that patients receive the forms of care best suited 
to their individual needs and that correspond to their own choices.
These two measures may contribute to creating a situation where patients’ 
care pathways no longer depend exclusively on a single nephrologist, but 
instead include a collegial dimension and, above all, take account of the patients’ 
own preferences.
In the same spirit, for all patients approaching the replacement therapy 
stage who are aged under 70 (and beyond, in the absence of obvious 
contraindications and in line with their wishes), a systematic pre-transplant 
consultation with a renal transplantation team could help to narrow the 
differences in access between social groups. 
Finally, the fee-for-service system for dialysis influences patient care choices 
and may be holding back the development of transplantation. In its annual 
report on the application of the 2015 laws on the financing of the French social 
security system, the Cour des comptes showed that the fee-for-service payments 
received by institutions, and the way in which independent nephrologists are 
paid to perform dialysis both create incentives favouring in-centre dialysis, 
the most high-tech and costly form of dialysis. These work to the detriment 
not only of other dialysis techniques and of access to transplantation, but also 
of care strategies aimed at slowing or stopping the development of renal disease 
before the replacement stage (Cour des comptes, 2015).
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To remedy this situation, the Cour des Comptes recommends that the 
system for reimbursing renal insufficiency treatment be modified with a view 
to rebalancing the budgets allocated to in-centre dialysis with respect to those 
for prevention, organ harvesting and transplantation. Such a reform would no 
doubt be decisive in attenuating the impact of social inequalities.
Patients also have a role to play. Their capacity to take an active part in 
their own care decisions and pathways and to emancipate themselves from 
the power of the physician are also important ways of reducing social inequalities. 
Organizations representing health system users could use therapeutic education 
and other support initiatives to raise patients’ awareness of their rights, better 
equip them to discuss with health professionals on an equal basis, without 
being spoken down to or infantilized, and find information, support, and 
resources. Such initiatives must give priority to the most vulnerable groups if 
they are to attenuate inequalities rather than amplify them.
These measures would also considerably reduce the proportion of health 
spending that goes to nephrology. In France, a year of dialysis costs the national 
health insurance system around €80,000 (Blotière et al., 2010). Spending linked 
to a transplant is approximately equal in the year of the operation, but then 
decreases sharply, to around €20,000 per year. The 71,000 ESRD patients in 
France receiving treatment by dialysis (55%) or kidney transplant (45%), 
represent an overall medical cost of around €4 billion; 82% of this amount, or 
around 3% of the total budget of the national health insurance system (around 
€140 billion), is spent on dialysis.
This is one of the most significant paradoxes in nephrology. Contrary to 
many other pathologies, the least expensive therapy for ESRD is also the most 
effective. It is not the wealthiest who represent the greatest cost to the healthcare 
system, but the poorest, who nonetheless continue to receive inferior care.
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Renal disease therapies
For patients with end-stage renal disease (ESRD), whose kidneys permanently 
cease to function, their survival depends on one of two “replacement techniques”: 
haemodialysis (or simply dialysis) and renal transplantation.
In haemodialysis (55% of patients in France), two modes of treatment are 
possible:
•	 “Autonomous”	hemodialysis	(30%	of	dialysis	patients):
- Home haemodialysis
Patients can undergo haemodialysis in their own home. A family member 
is generally required to be present to assist the patient in case of problems 
during the session.
- Self-care dialysis
Patients who do not wish to be treated at home or who do not have space 
to install the required equipment can use self-care dialysis. In this case, the 
patient goes to a local dialysis unit where there is one nurse for every six to 
eight patients, depending on their degree of autonomy.
•	 Non-autonomous	hemodialysis	(70%	of	dialysis	patients):
- In-centre haemodialysis
In this form of dialysis, nurses prepare the machine, connect and 
disconnect the patients’ blood supply, and monitor the session. A doctor is 
present during each session. Patients undergo three four-hour dialysis sessions 
per week.
- Hemodialysis in a medically supervised dialysis unit 
This type of unit is used by patients who are not autonomous, but who 
do not need such “close” medical supervision. A physician is not systematically 
present for every session.
For renal transplantation (45% of patients) there are two sources of organs 
- Deceased donors (85% of transplant patients)
- Living donors (15% of transplant patients)
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Christian Baudelot, Yvanie Caillé, Olivier GodeChot, Sylvie MerCier • Renal 
Diseases anD social inequalities in access to tRansplantation in FRance
Renal diseases are invisible and silent up to an advanced stage. Renal transplant is today the most effective 
therapy at all ages of life in terms of survival and quality of life, and is also the least expensive for French health 
system. Yet, whatever their age or sex, patients with a lower level of education less frequently receive transplants. 
Various independent factors produce these social inequalities: the nature of renal pathologies, resulting partly 
from patients' lifestyles; the degree of attention paid to initial symptoms and the existence of two types of 
replacement therapy (dialysis and transplant) practiced differently in the private and public sectors. Patients with 
the highest level of education are in a better position to negotiate the system than the others. The results 
presented in this article are based on data from two national surveys of renal patients conducted in 2011 and 
2012. 
Christian Baudelot, Yvanie Caillé, Olivier GodeChot, Sylvie MerCier • MalaDies 
Rénales et inégalités sociales D’accès à la gReFFe en FRance
Les maladies rénales sont invisibles et silencieuses jusqu’à un stade avancé. La transplantation est aujourd’hui le 
traitement le plus efficient à tous les âges de la vie en termes de survie et de qualité de vie, mais aussi pour le 
système de santé. Or, quels que soient le sexe ou l’âge, les patients les moins instruits y ont moins souvent accès 
que les autres en France. De nombreux facteurs indépendants concourent à ces inégalités sociales : la nature des 
pathologies rénales en partie produites par le mode de vie, l’attention prêtée aux premiers symptômes, mais 
aussi l’existence de deux traitements de suppléance (la dialyse et la transplantation) qui se pratiquent  dans des 
univers professionnels différents. Les mieux armés pour s’orienter dans ce système sont les patients les plus 
instruits. Les inégalités d’accès aux traitements entraînent à leur tour de fortes inégalités d’accès ou de maintien 
dans l’emploi. Les moins diplômés héritent d’emplois éprouvants physiquement qui sont rarement compatibles 
avec les séances de dialyse et un organisme affaibli.
Christian Baudelot, Yvanie Caillé, Olivier GodeChot, Sylvie MerCier • 
enFeRMeDaDes Renales y DesigualDaD social en el acceso al tRasplante en FRancia
Las enfermedades renales son invisibles y silenciosas hasta un estadio avanzado. El trasplante es actualmente el 
tratamiento más eficaz a toda edad, en términos de longevidad y de calidad de vida, y también para el sistema 
de salud. Ahora bien, en Francia, cualquiera que sea el sexo o la edad, los enfermos menos instruidos tienen un 
menor acceso al trasplante que los otros. Los factores que concurren a ello son numerosos: la naturaleza de las 
enfermedades renales provocada en parte por el modo de vida, la atención prestada a los primeros síntomas, y 
también la existencia de dos tratamientos supletorios (la diálisis y el trasplante) que se practican en universos 
profesionales diferentes. Los pacientes mejor armados para orientarse en este sistema son los más instruidos. 
Los resultados presentados en este artículo provienen de dos encuestas nacionales aplicadas a enfermos renales 
en 2011 y 2012. 
Keywords:  Nephrology, dialysis, transplantation, access to treatment, social inequalities, 
labour force participation rates.
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